First Mercantile Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

First Mercantile Trust’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$73K	Buy	721 +123	+21%	+$14.4K	0.01%	727
2021 Q2	$85K	Sell	598 -62	-9%	-$7K	0.01%	728
2021 Q1	$66K	Buy	660 +190	+40%	+$22.2K	0.01%	754
2020 Q4	$58K	Sell	470 -39	-8%	-$5.13K	0.01%	774
2020 Q3	$89K	Hold	509	–	–	0.01%	706
2020 Q2	$79K	Sell	509 -1,036	-67%	-$157K	0.01%	733
2020 Q1	$223K	Sell	1,545 -68	-4%	-$13.1K	0.03%	310
2019 Q4	$330K	Buy	1,613 +415	+35%	+$75.7K	0.04%	311
2019 Q3	$96K	Sell	1,198 -2	-0.2%	-$170	0.01%	704
2019 Q2	$113K	Sell	1,200 -136	-10%	-$11.7K	0.01%	604
2019 Q1	$114K	Sell	1,336 -60	-4%	-$4.98K	0.03%	625
2018 Q4	$78K	Sell	1,396 -652	-32%	-$39.8K	0.02%	712
2018 Q3	$167K	Buy	+2,048	New	+$144K	0.03%	566

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

First Mercantile Trust's RETA Position: Q3 2021 in Review

First Mercantile Trust increased its Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) stake by 21% in Q3 2021, buying an estimated $14.4K and bringing the position to 721 shares worth $73K. The position accounts for 0.01% of the portfolio, ranked #727.

First Mercantile Trust first reported a position in RETA in Q3 2018 and has held it in 13 quarters since. The position peaked at $330K in Q4 2019. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

First Mercantile Trust held 721 shares of Reata Pharmaceuticals, Inc. Class A Common Stock worth $73K as of Q3 2021.
First Mercantile Trust bought 123 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2021, an estimated $14.4K.
Reata Pharmaceuticals, Inc. Class A Common Stock made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #727 holding.
First Mercantile Trust first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and has held it in 13 quarters since.
First Mercantile Trust's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $330K in Q4 2019.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.